WealthStone, Inc. - Santen Pharmaceutical Co Ltd ownership

Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 1 filers reported holding Santen Pharmaceutical Co Ltd in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WealthStone, Inc. ownership history of Santen Pharmaceutical Co Ltd
ValueSharesWeighting
Q2 2019$1,055,000640.00%
Other shareholders
Santen Pharmaceutical Co Ltd shareholders Q3 2023
NameSharesValueWeighting ↓
RHUMBLINE ADVISERS 30$2730.00%
View complete list of Santen Pharmaceutical Co Ltd shareholders